Full access
Government News
Published Online: 5 August 2005

FDA Alert Covers Cymbalta

Publication: Psychiatric News
Volume 40, Number 15
https://doi.org/10.1176/pn.40.15.00400019b
Track CitationsAdd to favorites
In conjunction with its release of the public health advisory regarding increased risk of suicide in adults taking antidepressants, the FDA issued a separate FDA Alert involving duloxetine (Cymbalta) and suicidality in pediatric and adult patients.
The alert largely echoes the language of the advisory, noting that the FDA is “highlighting that adults being treated with any type of antidepressant medication, particularly those being treated for depression, should be watched closely for worsening of depression and for increased suicidal thinking or behavior.”
However, the alert goes on to say that “a higher than expected rate of suicide attempts was observed in the open-label extensions of controlled studies of Cymbalta for stress urinary incontinence (SUI) in women. An increased rate of suicidality was not seen in controlled trials of Cymbalta for treatment of depression or diabetic neuropathic pain (the approved indications for Cymbalta).”
Finally, the FDA Alert notes, “The FDA is evaluating additional data to determine the relationship, if any, between suicidality and Cymbalta use.”
The FDA Alert is posted at<www.fda.gov/cder/drug/infopage/duloxetine/default.htm>.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 40 • Number 15 • August 5, 2005
Pages: 19

History

Published online: 5 August 2005
Published in print: August 5, 2005

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.